ID

30225

Description

Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01005758

Link

https://clinicaltrials.gov/show/NCT01005758

Keywords

Versions (1)
  1. 5/22/18 5/22/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

May 22, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

No comments

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Leukemia NCT01005758

English

Eligibility Leukemia NCT01005758

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT01005758
Criteria
Description

Criteria

diagnosis of acute lymphoblastic leukemia (all)
Description

Acute lymphocytic leukemia

Data type

boolean

Alias
UMLS CUI [1]
C0023449
no known mature b-cell all*, defined by the presence of surface immunoglobulin, l3 morphology, t(8;14)(q24;q32), t(8;22), or t(2;8)
Description

Exclusion Burkitt Leukemia | Receptors, Antigen, B-Cell | t(8;14)(q24;q32) | Other Coding

Data type

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0006413
UMLS CUI [2]
C0034789
UMLS CUI [3]
C1515792
UMLS CUI [4]
C4331809
UMLS CUI [5]
C3846158
patients with t-cell surface markers and t(8;14)(q24;q11) are eligible note:
Description

T-cell surface markers | t(8;14)(q24;q11)

Data type

boolean

Alias
UMLS CUI [1,1]
C0039194
UMLS CUI [1,2]
C0699040
UMLS CUI [1,3]
C0005516
UMLS CUI [2]
C1515791
*patients with mature b-cell all will be removed from the study as soon as that diagnosis is made.
Description

Exclusion Burkitt Leukemia

Data type

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0006413
no secondary all (i.e., all arising after another malignancy)
Description

Exclusion Acute lymphocytic leukemia Secondary

Data type

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0023449
UMLS CUI [1,3]
C0175668
patient characteristics:
Description

Client Characteristics

Data type

boolean

Alias
UMLS CUI [1]
C0815172
not pregnant or nursing
Description

Pregnancy Absent | Breast Feeding Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
negative pregnancy test
Description

Pregnancy test negative

Data type

boolean

Alias
UMLS CUI [1]
C0427780
fertile patients must use effective contraception
Description

Fertility Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
no known hiv positivity (hiv testing is not required)
Description

HIV Seropositivity Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0019699
UMLS CUI [1,2]
C0332197
no comorbid medical condition that would, in the investigator's opinion, make participation in this study and adherence to the study guidelines a compromise to the study objectives
Description

Exclusion | Comorbidity compromises Study Subject Participation Status | Comorbidity compromises Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C2945640
UMLS CUI [2,3]
C2348568
UMLS CUI [3,1]
C0009488
UMLS CUI [3,2]
C2945640
UMLS CUI [3,3]
C0525058
no active psychiatric or mental illness that would make giving informed consent or careful clinical follow-up unlikely
Description

Exclusion | Mental disorders Informed Consent Unlikely | Mental disorders Follow-up Unlikely

Data type

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C0004936
UMLS CUI [2,2]
C0021430
UMLS CUI [2,3]
C0750558
UMLS CUI [3,1]
C0004936
UMLS CUI [3,2]
C3274571
UMLS CUI [3,3]
C0750558
prior concurrent therapy:
Description

Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1]
C0087111
no prior anti-leukemic therapy except ≤ 1 week of steroids, emergent radiotherapy to the mediastinum, hydroxyurea, or emergent leukapheresis
Description

Exclusion | Therapeutic procedure Leukemia Related | Exception Steroids | Exception Radiotherapy to mediastinum Emergency | Exception Hydroxyurea | Exception Leukapheresis Emergency

Data type

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0023418
UMLS CUI [2,3]
C0439849
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0038317
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C4049191
UMLS CUI [4,3]
C0013956
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0020402
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0023416
UMLS CUI [6,3]
C0013956
patients who have received steroids within the past 7 days are eligible but will not receive steroid prophase therapy on study
Description

Steroids Recently

Data type

boolean

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C0332185
no concurrent chronic steroids or anti-metabolite therapy
Description

Exclusion Criteria | Steroids chronic | Antimetabolites chronic

Data type

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0038317
UMLS CUI [2,2]
C0205191
UMLS CUI [3,1]
C0003376
UMLS CUI [3,2]
C0205191
Back to the top of the page

Similar models

Eligibility Leukemia NCT01005758

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT01005758
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Acute lymphocytic leukemia
Item
diagnosis of acute lymphoblastic leukemia (all)
boolean
C0023449 (UMLS CUI [1])
Exclusion Burkitt Leukemia | Receptors, Antigen, B-Cell | t(8;14)(q24;q32) | Other Coding
Item
no known mature b-cell all*, defined by the presence of surface immunoglobulin, l3 morphology, t(8;14)(q24;q32), t(8;22), or t(2;8)
boolean
C2828389 (UMLS CUI [1,1])
C0006413 (UMLS CUI [1,2])
C0034789 (UMLS CUI [2])
C1515792 (UMLS CUI [3])
C4331809 (UMLS CUI [4])
C3846158 (UMLS CUI [5])
T-cell surface markers | t(8;14)(q24;q11)
Item
patients with t-cell surface markers and t(8;14)(q24;q11) are eligible note:
boolean
C0039194 (UMLS CUI [1,1])
C0699040 (UMLS CUI [1,2])
C0005516 (UMLS CUI [1,3])
C1515791 (UMLS CUI [2])
Exclusion Burkitt Leukemia
Item
*patients with mature b-cell all will be removed from the study as soon as that diagnosis is made.
boolean
C2828389 (UMLS CUI [1,1])
C0006413 (UMLS CUI [1,2])
Exclusion Acute lymphocytic leukemia Secondary
Item
no secondary all (i.e., all arising after another malignancy)
boolean
C2828389 (UMLS CUI [1,1])
C0023449 (UMLS CUI [1,2])
C0175668 (UMLS CUI [1,3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Pregnancy test negative
Item
negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
HIV Seropositivity Absent
Item
no known hiv positivity (hiv testing is not required)
boolean
C0019699 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Exclusion | Comorbidity compromises Study Subject Participation Status | Comorbidity compromises Protocol Compliance
Item
no comorbid medical condition that would, in the investigator's opinion, make participation in this study and adherence to the study guidelines a compromise to the study objectives
boolean
C2828389 (UMLS CUI [1])
C0009488 (UMLS CUI [2,1])
C2945640 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
C0009488 (UMLS CUI [3,1])
C2945640 (UMLS CUI [3,2])
C0525058 (UMLS CUI [3,3])
Exclusion | Mental disorders Informed Consent Unlikely | Mental disorders Follow-up Unlikely
Item
no active psychiatric or mental illness that would make giving informed consent or careful clinical follow-up unlikely
boolean
C2828389 (UMLS CUI [1])
C0004936 (UMLS CUI [2,1])
C0021430 (UMLS CUI [2,2])
C0750558 (UMLS CUI [2,3])
C0004936 (UMLS CUI [3,1])
C3274571 (UMLS CUI [3,2])
C0750558 (UMLS CUI [3,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Exclusion | Therapeutic procedure Leukemia Related | Exception Steroids | Exception Radiotherapy to mediastinum Emergency | Exception Hydroxyurea | Exception Leukapheresis Emergency
Item
no prior anti-leukemic therapy except ≤ 1 week of steroids, emergent radiotherapy to the mediastinum, hydroxyurea, or emergent leukapheresis
boolean
C2828389 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0023418 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0038317 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C4049191 (UMLS CUI [4,2])
C0013956 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0020402 (UMLS CUI [5,2])
C1705847 (UMLS CUI [6,1])
C0023416 (UMLS CUI [6,2])
C0013956 (UMLS CUI [6,3])
Steroids Recently
Item
patients who have received steroids within the past 7 days are eligible but will not receive steroid prophase therapy on study
boolean
C0038317 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Exclusion Criteria | Steroids chronic | Antimetabolites chronic
Item
no concurrent chronic steroids or anti-metabolite therapy
boolean
C0680251 (UMLS CUI [1])
C0038317 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0003376 (UMLS CUI [3,1])
C0205191 (UMLS CUI [3,2])
Back to the top of the page 

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial